Abiomed Company Profile

Aggregated data from the web about Abiomed

Company Name	Abiomed
Website	https://www.abiomed.com
Snippet	Abiomed Breethe OXY-1 System™ The OXY-1 System is an easy-to-use, compact cardiopulmonary support system, with an integrated oxygen concentrator that provides an independent oxygen source designed to support mobility.
Type	Public
Founded	1981
Revenue	US$769.43 million (2019)
Website	abiomed.com
Industry	Medical Devices
Products	Cardiovascular medical implant devices
Traded as	Nasdaq: ABMD, S&P 500 component
Key people	Michael R. Minogue, CEOThorston Siess, CTOChuck Simonton, CMODr. David M. Weber, COOAndrew Greenfield, CCO
Net income	US$259.02 million (2019)
Headquarters	Danvers, Massachusetts, U.S.
Total assets	US$1,054.3 million (2019)
Total equity	US$936.89 million (2019)
Operating income	US$224.81 million (2019)
Number of employees	1,371 (March 31, 2019)

Abiomed is part of the United States company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.